In line with these observations, our results show an augmented migration of PBMCs based on a TRAIL mediated activation of RelA/ NF-κB and subsequent CX3CL1 expression in pancreatic cancer cells. The gene discussed is CX3CL1; the disease is familial pancreatic carcinoma.